Found 7 matching trials
Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
PHASE1This is a single arm, open-label, dose escalation clinical study to evaluat...
Location
Beijing Cancer Hospital
Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies
PHASE2The goal of this open, single-arm practical, phase II, clinical study is to...
Status
Active Not Recruiting
Location
Union Hospital, Huazhong University of Science and Technology
Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
PHASE1This is a single arm, open-label, dose escalation clinical study to evaluat...
A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
PHASE4To evaluate the efficacy and safety of post-marketing Regiorense injection ...
Location
Multiple Locations
CD19-targeted CAR T Cells (JWCAR029) for Primary Refractory Diffuse Large B Cell Lymphoma
PHASE1This is a phase I, open-label, single-arm, multicenter study to assess the ...
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
PHASE4To observe the efficacy and safety of a second infusion of relma-cel inject...
Location
NO.197, Ruijin Er Road
Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma
PHASE2This study aims to evaluate the efficacy and safety of Relma-cel in the tre...
Location
Beljing Tiantan Hospital, Capttal Medical, University